IRIS
TORTI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.419
EU - Europa 1.585
AS - Asia 1.573
SA - Sud America 20
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
Totale 7.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.283
SG - Singapore 1.154
IT - Italia 857
CN - Cina 295
SE - Svezia 242
GB - Regno Unito 240
CA - Canada 129
IN - India 63
DE - Germania 60
NL - Olanda 39
HK - Hong Kong 24
CZ - Repubblica Ceca 22
RO - Romania 19
FR - Francia 17
UA - Ucraina 17
FI - Finlandia 13
BR - Brasile 12
RU - Federazione Russa 11
A2 - ???statistics.table.value.countryCode.A2??? 9
ES - Italia 9
AU - Australia 6
CL - Cile 6
EU - Europa 5
GR - Grecia 5
JP - Giappone 5
MX - Messico 5
NG - Nigeria 5
PL - Polonia 5
AT - Austria 4
IE - Irlanda 4
IR - Iran 4
NO - Norvegia 4
TR - Turchia 4
AM - Armenia 3
CH - Svizzera 3
EE - Estonia 3
EG - Egitto 3
IL - Israele 3
KR - Corea 3
LV - Lettonia 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IQ - Iraq 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
TZ - Tanzania 2
BD - Bangladesh 1
BE - Belgio 1
BW - Botswana 1
DZ - Algeria 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 7.637
Salva come PNG Salva come JPEG
Città #
Chandler 900
Santa Clara 401
Milan 339
Singapore 339
Princeton 334
Lawrence 332
Wilmington 216
London 208
Chicago 201
Ottawa 123
Des Moines 98
Ashburn 82
Boardman 58
Rome 44
Pune 34
Norwalk 32
Guangzhou 31
Shanghai 31
Redwood City 29
Catanzaro 28
Palermo 24
Olomouc 22
Woodbridge 22
Crotone 20
Hong Kong 20
San Nicola Manfredi 20
Wuhan 20
Houston 19
Fairfield 17
Beijing 16
Naples 15
Los Angeles 14
Shenzhen 14
Cosenza 13
Munich 13
Hanover 12
Helsinki 12
Rende 12
Rui'an 12
Redmond 11
Settingiano 10
Padova 9
Taranto 9
Ann Arbor 8
Amsterdam 7
Bari 7
Quanzhou 7
Assago 6
Falls Church 6
Fayetteville 6
Jiaxing 6
Maryland Heights 6
Reggio Calabria 6
Catania 5
San Francisco 5
Vijayawada 5
Florence 4
Genoa 4
Monheim 4
Nanjing 4
Pisa 4
São Paulo 4
West Jordan 4
Casavatore 3
Cascina 3
Dearborn 3
Las Vegas 3
Mexico City 3
Napoli 3
Paola 3
Reggio Emilia 3
Ricadi 3
Rosarno 3
San Mateo 3
Seattle 3
Sesto San Giovanni 3
Tappahannock 3
Voghera 3
Xi'an 3
Agrigento 2
Amman 2
Ardea 2
Augusta 2
Aversa 2
Badalona 2
Barcelona 2
Borås 2
Cambridge 2
Caserta 2
Casoria 2
Castelfiorentino 2
Cerignola 2
Chisinau 2
Clarksburg 2
Clifton 2
Columbia 2
Columbus 2
Dar es Salaam 2
Denver 2
Dongyang 2
Totale 4.414
Salva come PNG Salva come JPEG
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 93
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 74
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 51
Ochrobactrum anthropi 42
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 42
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 42
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 42
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 41
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 39
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 39
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 38
Therapy with RAS inhibitors during the COVID-19 pandemic 38
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 37
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 37
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 37
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 37
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 36
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 36
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 36
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 36
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 36
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 35
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 35
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 35
A king in the CASTLE? Optimum initial HIV protease inhibitor. 35
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals 35
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 34
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 34
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 34
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 34
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 34
Allozyme divergence and phylogenetic relationships among species of tephritid flies 33
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 33
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 33
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 33
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 32
RegaDB: community-driven data management and analysis for infectious diseases 32
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro 32
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009 31
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 31
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 31
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 31
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 31
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmacoeconomic implications in a population-based setting 31
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 31
Increasing clinical virulence in two decades of the Italian HIV epidemic 31
Valutazione economica dei trattamenti anti-HIV: lo studio di coorte I.C.O.N.A. 31
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 31
Challenging clinical cases in HCV infection 31
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 31
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 31
Evolving phenotypes of non-hospitalized patients that indicate long COVID 31
Early virological failure after tenofovir plus didanosine plus efavirenz combination in HIV-positive patients upon starting antiretroviral therapy 30
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 30
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 30
Current concerns in HIV antiretroviral therapy 30
R211K and L214F ho not invariably confer high level phenotypic resistance to thymidine analogs in zidovndine-naive patients with M184V 30
HIV-1 pharmacoresistance: clinical and therapeutic implications 30
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 30
"Solving the puzzle" of current HAART: What key strategic trials are needed? 30
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia 30
Genotyping for guiding drug choice in human immunodeficiency virus-infected children failing multiple antiretroviral treatment regimens 30
Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study 30
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 30
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. 30
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 30
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 29
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 29
Risk factors for myocardial infarction in HIV positive patients 29
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 29
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 29
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients 29
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 29
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 29
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 29
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis. 29
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 29
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 28
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 28
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 28
Mature and developing visual system of Ceratitis capitata (Diptera, Tephritidae): histochemical evidence of nitric oxide synthase in the wild type and the white eye mutant strains 28
Factors influencing the normalization of CD4+T-cell count, percentage and CD4+/CD8+T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 28
Use of colistin in adult patients: a cross-sectional study 28
Predictors of AIDS-defining events among advanced naïve patients after HAART. 28
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 28
null 27
Characterization and evolution of mariner elements from closely related species of fruit flies (Diptera : Tephritidae) 27
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients 27
Molecular characterization and chromosomal localization of female-specific genes from the Mediterranean fruit fly Ceratitis capitata (Diptera : Tephritidae) 27
Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound. 27
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 27
MASTER Study Group. Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function 27
HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatment 27
Long-term CD4+T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 27
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort 27
Evolution of Antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 27
Infezione da HIV. Epidemiologia 27
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients 27
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 27
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 26
Totale 3.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020193 0 0 0 0 0 0 0 0 0 0 62 131
2020/2021291 19 4 91 19 17 31 16 32 34 16 3 9
2021/2022880 9 3 12 236 30 17 41 216 58 104 146 8
2022/20232.570 684 110 20 276 286 244 14 160 402 169 167 38
2023/20241.134 237 147 80 77 69 290 36 24 26 25 60 63
2024/20252.693 543 273 136 136 236 460 67 142 458 232 10 0
Totale 7.886